Cyclosporine (CsA)

DRUG8 trials

Conditions

Chronic Kidney FailureGraft Versus Host DiseaseHematopoietic Stem Cell TransplantationHemophagocytic SyndromeKidney TransplantationLower-risk Myelodysplastic SyndromesSevere Aplastic Anemia (SAA)Transfusion-dependent Non-severe Aplastic Anemia

Phase 2

Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transplantation

CompletedNCT00948727

Assistance Publique - Hôpitaux de ParisGraft Versus Host Disease, Hematopoietic Stem Cell Transplantation

Start: 2004-01-31End: 2008-06-30Updated: 2009-10-01

TRACK-TBI Precision Medicine Part 3 - Option II

Enrolling by invitationNCT06790095

University of California, San FranciscoTraumatic Brain Injury

Start: 2026-06-01End: 2027-05-01Target: 26Updated: 2026-05-12

CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAA

WithdrawnNCT07523009

Peking Union Medical College HospitalSevere Aplastic Anemia (SAA), Transfusion-dependent Non-severe Aplastic Anemia

Start: 2026-06-01End: 2029-12-01Updated: 2026-06-04

CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAA

Not yet recruitingNCT07558434

Peking Union Medical College HospitalSevere Aplastic Anemia (SAA), Transfusion-dependent Non-severe Aplastic Anemia

Start: 2026-04-01End: 2029-12-01Target: 43Updated: 2026-04-30

Phase 3

Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)

CompletedNCT00256750

Bristol-Myers SquibbChronic Kidney Failure, Kidney Transplantation

Start: 2005-03-31End: 2015-04-30Updated: 2016-08-19

Enarodustat + CsA vs CsA in Newly Diagnosed TD-NSAA

Not yet recruitingNCT07548671

Peking Union Medical College HospitalTransfusion-dependent Non-severe Aplastic Anemia

Start: 2026-04-01End: 2029-12-01Target: 90Updated: 2026-04-23

rhTPO + CsA vs CsA in the Treatment of LR-MDS With Thrombocytopenia

Not yet recruitingNCT07653581

Peking Union Medical College HospitalLower-risk Myelodysplastic Syndromes

Start: 2026-06-01End: 2029-12-01Target: 78Updated: 2026-06-17

Unknown Phase

A Randomized Controlled Study of High-dose Cyclophosphamide Induction Therapy in Adult Patients With HLH

RecruitingNCT05936086

shifeng LouHemophagocytic Syndrome

Start: 2023-04-20End: 2027-05-20Target: 160Updated: 2023-08-30

Related Papers

Belatacept and Long-Term Outcomes in Kidney Transplantation